Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

Articles published in
Lancet Infect Dis
    September 2021
  1. KIANG MV, Chin ET, Huynh BQ, Chapman LAC, et al
    Addendum needed on COVID-19 travel study - Authors' reply.
    Lancet Infect Dis. 2021 Sep 15. pii: S1473-3099(21)00562.
    >> Share

  2. ALTENBERG L
    Addendum needed on COVID-19 travel study.
    Lancet Infect Dis. 2021 Sep 15. pii: S1473-3099(21)00454.
    >> Share

  3. XIA S, Zhang Y, Wang Y, Wang H, et al
    Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial.
    Lancet Infect Dis. 2021 Sep 15. pii: S1473-3099(21)00462.
    >> Share

  4. MOSTAGHIMI D, Valdez CN, Larson HT, Kalinich CC, et al
    Prevention of host-to-host transmission by SARS-CoV-2 vaccines.
    Lancet Infect Dis. 2021 Sep 14. pii: S1473-3099(21)00472.
    >> Share

  5. ADER F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, et al
    Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
    Lancet Infect Dis. 2021 Sep 14. pii: S1473-3099(21)00485.
    >> Share

  6. CHOUDHARY OP, Choudhary P, Singh I
    India's COVID-19 vaccination drive: key challenges and resolutions.
    Lancet Infect Dis. 2021 Sep 13. pii: S1473-3099(21)00567.
    >> Share

  7. LACERDA MVG, Bargieri DY
    Protection against COVID-19: beyond antibodies.
    Lancet Infect Dis. 2021 Sep 9. pii: S1473-3099(21)00561.
    >> Share

  8. SAURE D, O'Ryan M, Torres JP, Zuniga M, et al
    Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Lancet Infect Dis. 2021 Sep 9. pii: S1473-3099(21)00479.
    >> Share

  9. JUTHANI PV, Gupta A, Borges KA, Price CC, et al
    Hospitalisation among vaccine breakthrough COVID-19 infections.
    Lancet Infect Dis. 2021 Sep 7. pii: S1473-3099(21)00558.
    >> Share

  10. BAGER P, Wohlfahrt J, Rasmussen M, Albertsen M, et al
    Hospitalisation associated with SARS-CoV-2 delta variant in Denmark.
    Lancet Infect Dis. 2021 Sep 3. pii: S1473-3099(21)00580.
    >> Share

  11. ANTONELLI M, Penfold RS, Merino J, Sudre CH, et al
    Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Lancet Infect Dis. 2021 Sep 1. pii: S1473-3099(21)00460.
    >> Share

  12. BALAKRISHNAN VS
    Memorialising Trump's pandemic (non-)response.
    Lancet Infect Dis. 2021;21:1231.
    >> Share

  13. BAGCCHI S
    Travel notice issued as Venezuela faces health system crisis.
    Lancet Infect Dis. 2021;21:1219.
    >> Share

  14. DE AMBROGI M
    Images of a world facing a pandemic.
    Lancet Infect Dis. 2021;21:1225-1229.
    >> Share

    August 2021
  15. TWOHIG KA, Nyberg T, Zaidi A, Thelwall S, et al
    Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.
    Lancet Infect Dis. 2021 Aug 27. pii: S1473-3099(21)00475.
    >> Share

  16. LECHIEN JR, Saussez S
    Importance of epidemiological factors in the evaluation of transmissibility and clinical severity of SARS-CoV-2 variants.
    Lancet Infect Dis. 2021 Aug 27. pii: S1473-3099(21)00474.
    >> Share

  17. TEMPE DK
    Is indiscriminate use of medicines the main reason for problems faced during the second wave of COVID-19 in India?
    Lancet Infect Dis. 2021 Aug 24. pii: S1473-3099(21)00450.
    >> Share

  18. BEAUTE J, Adlhoch C, Bundle N, Melidou A, et al
    Testing indicators to monitor the COVID-19 pandemic.
    Lancet Infect Dis. 2021 Aug 24. pii: S1473-3099(21)00461.
    >> Share

  19. UDWADIA Z, Balsari S, Ghafur A
    Is indiscriminate use of medicines the main reason for problems faced during the second wave of COVID-19 in India? - Authors' reply.
    Lancet Infect Dis. 2021 Aug 24. pii: S1473-3099(21)00480.
    >> Share

  20. CIRILLO N, Doan R
    The association between COVID-19 vaccination and Bell's palsy.
    Lancet Infect Dis. 2021 Aug 16. pii: S1473-3099(21)00467.
    >> Share

  21. WAN EYF, Chui CSL, Lai FTT, Chan EWY, et al
    Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study.
    Lancet Infect Dis. 2021 Aug 16. pii: S1473-3099(21)00451.
    >> Share

  22. MORAN E, Cook T, Goodman AL, Gupta RK, et al
    Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials.
    Lancet Infect Dis. 2021 Aug 16. pii: S1473-3099(21)00464.
    >> Share

  23. LI Y, Nair H
    How reliable are COVID-19 burden estimates for India?
    Lancet Infect Dis. 2021 Aug 13. pii: S1473-3099(21)00422.
    >> Share

  24. SNELL LB, Cliff PR, Charalampous T, Alcolea-Medina A, et al
    Rapid genome sequencing in hospitals to identify potential vaccine-escape SARS-CoV-2 variants.
    Lancet Infect Dis. 2021 Aug 13. pii: S1473-3099(21)00482.
    >> Share

  25. LAXMINARAYAN R, B CM, G VT, Arjun Kumar KV, et al
    SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
    Lancet Infect Dis. 2021 Aug 13. pii: S1473-3099(21)00393.
    >> Share

  26. THE LANCET INFECTIOUS DISEASES
    COVID-19 vaccine equity and booster doses.
    Lancet Infect Dis. 2021 Aug 12. pii: S1473-3099(21)00486.
    >> Share

  27. KADAMBARI S, Vanderslott S
    Lessons about COVID-19 vaccine hesitancy among minority ethnic people in the UK.
    Lancet Infect Dis. 2021 Aug 9. pii: S1473-3099(21)00404.
    >> Share

  28. TODSEN T, Kirkby N, Benfield T
    Is oropharyngeal sampling a reliable test to detect SARS-CoV-2?
    Lancet Infect Dis. 2021 Aug 4. pii: S1473-3099(21)00395.
    >> Share

  29. TSANG NNY, So HC, Ip DKM
    Is oropharyngeal sampling a reliable test to detect SARS-CoV-2? - Authors' reply.
    Lancet Infect Dis. 2021 Aug 4. pii: S1473-3099(21)00402.
    >> Share

  30. CHEN PZ, Koopmans M, Fisman DN, Gu FX, et al
    Understanding why superspreading drives the COVID-19 pandemic but not the H1N1 pandemic.
    Lancet Infect Dis. 2021 Aug 2. pii: S1473-3099(21)00406.
    >> Share

  31. LONG CM, Marzi A
    Biodefence research two decades on: worth the investment?
    Lancet Infect Dis. 2021;21:e222-e233.
    >> Share

  32. BALAKRISHNAN VS
    Impact of COVID-19 on migrants and refugees.
    Lancet Infect Dis. 2021;21:1076-1077.
    >> Share

  33. ESSO L, Epee E, Bilounga C, Abah A, et al
    Cameroon's bold response to the COVID-19 pandemic during the first and second waves.
    Lancet Infect Dis. 2021;21:1064-1065.
    >> Share

  34. LOTFINEJAD N, Peters A, Tartari E, Fankhauser-Rodriguez C, et al
    Hand hygiene in health care: 20 years of ongoing advances and perspectives.
    Lancet Infect Dis. 2021;21:e209-e221.
    >> Share

  35. KIRBY T
    Akiko Iwasaki-aiming at making vaccines better.
    Lancet Infect Dis. 2021;21:1082.
    >> Share

  36. BURKE MJ, Del Rio C
    Long COVID has exposed medicine's blind-spot.
    Lancet Infect Dis. 2021;21:1062-1064.
    >> Share

    July 2021
  37. TENBUSCH M, Schumacher S, Vogel E, Priller A, et al
    Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2.
    Lancet Infect Dis. 2021 Jul 29. pii: S1473-3099(21)00420.
    >> Share

  38. WU S, Huang J, Zhang Z, Wu J, et al
    Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial.
    Lancet Infect Dis. 2021 Jul 26. pii: S1473-3099(21)00396.
    >> Share

  39. MOJICA MF, Rossi MA, Vila AJ, Bonomo RA, et al
    The urgent need for metallo-beta-lactamase inhibitors: an unattended global threat.
    Lancet Infect Dis. 2021 Jul 8. pii: S1473-3099(20)30868.
    >> Share

  40. GLYNN JR, Dube A, Fielding K, Crampin AC, et al
    The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi.
    Lancet Infect Dis. 2021 Jul 5. pii: S1473-3099(20)30994.
    >> Share

  41. BURKI T
    Global COVID-19 vaccine inequity.
    Lancet Infect Dis. 2021;21:922-923.
    >> Share

  42. ADHIKARI B, Cheah PY
    Vaccine hesitancy in the COVID-19 era.
    Lancet Infect Dis. 2021 Jul 1. pii: S1473-3099(21)00390.
    >> Share

  43. LARKIN M
    Mask confusion in NYC with abrupt CDC guidance changes.
    Lancet Infect Dis. 2021;21:921.
    >> Share

  44. PANDEY A, Galvani AP
    Role of the G20 in safe reopening of international travel.
    Lancet Infect Dis. 2021;21:919.
    >> Share

  45. BAGCCHI S
    Measles immunisation gaps in Africa.
    Lancet Infect Dis. 2021;21:918.
    >> Share

  46. RANA S, Shah R, Ahmed S, Mothabbir G, et al
    Post-disruption catch-up of child immunisation and health-care services in Bangladesh.
    Lancet Infect Dis. 2021;21:913.
    >> Share

    June 2021
  47. GILES B, Meredith P, Robson S, Smith G, et al
    The SARS-CoV-2 B.1.1.7 variant and increased clinical severity-the jury is out.
    Lancet Infect Dis. 2021 Jun 28. pii: S1473-3099(21)00356.
    >> Share

  48. ZOU X, Cao B
    COVID-19 vaccines for children younger than 12 years: are we ready?
    Lancet Infect Dis. 2021 Jun 28. pii: S1473-3099(21)00384.
    >> Share

  49. HAN B, Song Y, Li C, Yang W, et al
    Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial.
    Lancet Infect Dis. 2021 Jun 28. pii: S1473-3099(21)00319.
    >> Share

  50. SHROTRI M, Krutikov M, Palmer T, Giddings R, et al
    Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
    Lancet Infect Dis. 2021 Jun 23. pii: S1473-3099(21)00289.
    >> Share

  51. PRENDECKI M, Willicombe M
    Single-dose SARS-CoV-2 vaccination efficacy in the elderly.
    Lancet Infect Dis. 2021 Jun 23. pii: S1473-3099(21)00354.
    >> Share

  52. HYAMS C, Marlow R, Maseko Z, King J, et al
    Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.
    Lancet Infect Dis. 2021 Jun 23. pii: S1473-3099(21)00330.
    >> Share

  53. CEVIK M, Mishra S
    SARS-CoV-2 variants and considerations of inferring causality on disease severity.
    Lancet Infect Dis. 2021 Jun 22. pii: S1473-3099(21)00338.
    >> Share

  54. PATONE M, Thomas K, Hatch R, Tan PS, et al
    Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
    Lancet Infect Dis. 2021 Jun 22. pii: S1473-3099(21)00318.
    >> Share

  55. BAGER P, Wohlfahrt J, Fonager J, Rasmussen M, et al
    Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.
    Lancet Infect Dis. 2021 Jun 22. pii: S1473-3099(21)00290.
    >> Share

  56. JENA A
    COVID-19 and SOS tweets in India.
    Lancet Infect Dis. 2021 Jun 21. pii: S1473-3099(21)00355.
    >> Share

  57. THE LANCET INFECTIOUS DISEASES
    Should we vaccinate children against SARS-CoV-2?
    Lancet Infect Dis. 2021 Jun 10. pii: S1473-3099(21)00339.
    >> Share

  58. BALSARI S, Udwadia Z, Shaikh A, Ghafur A, et al
    Contextualising evidence-based recommendations for the second wave of the COVID-19 pandemic in India.
    Lancet Infect Dis. 2021 Jun 8. pii: S1473-3099(21)00329.
    >> Share

  59. OZONOFF A, Nanishi E, Levy O
    Bell's palsy and SARS-CoV-2 vaccines-an unfolding story - Authors' reply.
    Lancet Infect Dis. 2021 Jun 7. pii: S1473-3099(21)00323.
    >> Share

  60. CIRILLO N, Doan R
    Bell's palsy and SARS-CoV-2 vaccines-an unfolding story.
    Lancet Infect Dis. 2021 Jun 7. pii: S1473-3099(21)00273.
    >> Share

  61. MOGHADAS SM, Sah P, Vilches TN, Galvani AP, et al
    Can the USA return to pre-COVID-19 normal by July 4?
    Lancet Infect Dis. 2021 Jun 2. pii: S1473-3099(21)00324.
    >> Share

  62. BURKI T
    HIV in the age of COVID-19.
    Lancet Infect Dis. 2021;21:774-775.
    >> Share

  63. VASAN S, Pitisuttithum P
    Vaccine development lessons between HIV and COVID-19.
    Lancet Infect Dis. 2021;21:759-761.
    >> Share

  64. HOLT E
    Russia's faltering vaccination programme.
    Lancet Infect Dis. 2021;21:772.
    >> Share

  65. KONDRATIUK AL, Pillay TD, Kon OM, Lalvani A, et al
    A conceptual framework to accelerate the clinical impact of evolving research into long COVID.
    Lancet Infect Dis. 2021;21:756-757.
    >> Share

    May 2021
  66. MANDENG N, Fai KN, Bebell LM, Boum Y, et al
    Negative antigen RDT and RT-PCR results do not rule out COVID-19 if clinical suspicion is strong - Authors' reply.
    Lancet Infect Dis. 2021 May 28. pii: S1473-3099(21)00288.
    >> Share

  67. LEKPA FK, Njonnou SRS, Balti E, Luma HN, et al
    Negative antigen RDT and RT-PCR results do not rule out COVID-19 if clinical suspicion is strong.
    Lancet Infect Dis. 2021 May 28. pii: S1473-3099(21)00271.
    >> Share

  68. CHEN Y, Shen H, Huang R, Tong X, et al
    Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac.
    Lancet Infect Dis. 2021 May 27. pii: S1473-3099(21)00287.
    >> Share

  69. REVOLLO B, Blanco I, Soler P, Toro J, et al
    Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial.
    Lancet Infect Dis. 2021 May 27. pii: S1473-3099(21)00268.
    >> Share

  70. PEELING RW, Heymann DL
    Innovations in COVID-19 testing: the road from pandemic response to control.
    Lancet Infect Dis. 2021 May 27. pii: S1473-3099(21)00291.
    >> Share

  71. HUSSAINI SMQ
    A prescription for fair housing during the COVID-19 pandemic.
    Lancet Infect Dis. 2021 May 25. pii: S1473-3099(21)00257.
    >> Share

  72. SIMON F, Watson H, Meynard JB, de Santi VP, et al
    What chikungunya teaches us about COVID-19.
    Lancet Infect Dis. 2021 May 19. pii: S1473-3099(21)00272.
    >> Share

  73. RAMANATHAN M, Ferguson ID, Miao W, Khavari PA, et al
    SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity.
    Lancet Infect Dis. 2021 May 19. pii: S1473-3099(21)00262.
    >> Share

  74. DAL-RE R, Bekker LG, Gluud C, Holm S, et al
    Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities.
    Lancet Infect Dis. 2021 May 18. pii: S1473-3099(21)00263.
    >> Share

  75. THE LANCET INFECTIOUS DISEASES
    The rocky road to universal COVID-19 vaccination.
    Lancet Infect Dis. 2021 May 14. pii: S1473-3099(21)00275.
    >> Share

  76. HUANG L, Cao B
    Post-acute conditions of patients with COVID-19 not requiring hospital admission.
    Lancet Infect Dis. 2021 May 10. pii: S1473-3099(21)00225.
    >> Share

  77. LUND LC, Hallas J, Nielsen H, Koch A, et al
    Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study.
    Lancet Infect Dis. 2021 May 10. pii: S1473-3099(21)00211.
    >> Share

  78. HAMILTON WL, Fieldman T, Jahun A, Warne B, et al
    Applying prospective genomic surveillance to support investigation of hospital-onset COVID-19.
    Lancet Infect Dis. 2021 May 10. pii: S1473-3099(21)00251.
    >> Share

  79. PEELING RW, Olliaro P, Boeras D, Fongwen N, et al
    SARS-CoV-2 rapid antigen detection tests - Authors' reply.
    Lancet Infect Dis. 2021 May 4. pii: S1473-3099(21)00250.
    >> Share

  80. FOUZAS S
    SARS-CoV-2 rapid antigen detection tests.
    Lancet Infect Dis. 2021 May 4. pii: S1473-3099(21)00206.
    >> Share

  81. WEITZEL T, Perez C, Tapia D, Legarraga P, et al
    SARS-CoV-2 rapid antigen detection tests.
    Lancet Infect Dis. 2021 May 4. pii: S1473-3099(21)00249.
    >> Share

  82. SCHINDLER O, Steiner G, Trattner E, Schmon E, et al
    Bilateral infiltrates in a health-care worker during the COVID-19 pandemic.
    Lancet Infect Dis. 2021;21:742.
    >> Share

  83. NORTON A, Olliaro P, Sigfrid L, Carson G, et al
    Long COVID: tackling a multifaceted condition requires a multidisciplinary approach.
    Lancet Infect Dis. 2021;21:601-602.
    >> Share

  84. SCHWARTZ M
    MIS-C: post-infectious syndrome or persistent infection?
    Lancet Infect Dis. 2021;21:e116.
    >> Share

  85. MACKENZIE G
    A year and a day of #Covid19uk tweets.
    Lancet Infect Dis. 2021;21:616.
    >> Share

  86. BURKI T
    Infectious diseases in Yemen.
    Lancet Infect Dis. 2021;21:610-611.
    >> Share

  87. SAMARASEKERA U
    CEPI prepares for future pandemics and epidemics.
    Lancet Infect Dis. 2021;21:608.
    >> Share

  88. BARKSBY R
    1st Women in Malaria conference.
    Lancet Infect Dis. 2021;21:607.
    >> Share

  89. SIE A, Hanefeld J, Chaponda M, Chico RM, et al
    Congenital malformations in sub-Saharan Africa-warnings of a silent epidemic?
    Lancet Infect Dis. 2021;21:594-596.
    >> Share

    April 2021
  90. DRURY RE, O'Connor D
    Symptom study app provides real-world data on COVID-19 vaccines.
    Lancet Infect Dis. 2021 Apr 27. pii: S1473-3099(21)00264.
    >> Share

  91. MENNI C, Klaser K, May A, Polidori L, et al
    Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study.
    Lancet Infect Dis. 2021 Apr 27. pii: S1473-3099(21)00224.
    >> Share

  92. GILBERT SC, Lambe T
    Recombinant protein vaccines against SARS-CoV-2.
    Lancet Infect Dis. 2021 Apr 19. pii: S1473-3099(21)00227.
    >> Share

  93. GOEPFERT PA, Fu B, Chabanon AL, Bonaparte MI, et al
    Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study.
    Lancet Infect Dis. 2021 Apr 19. pii: S1473-3099(21)00147.
    >> Share

  94. CHAPPELL KJ, Mordant FL, Li Z, Wijesundara DK, et al
    Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial.
    Lancet Infect Dis. 2021 Apr 19. pii: S1473-3099(21)00200.
    >> Share

  95. OBARO S
    COVID-19 herd immunity by immunisation: are children in the herd?
    Lancet Infect Dis. 2021 Apr 19. pii: S1473-3099(21)00212.
    >> Share

  96. SPINELLI MA, Rutherford G, Gandhi M
    Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases - Authors' reply.
    Lancet Infect Dis. 2021 Apr 14. pii: S1473-3099(21)00210.
    >> Share

  97. TRUNFIO M, Calcagno A, Bonora S, Di Perri G, et al
    Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases.
    Lancet Infect Dis. 2021 Apr 14. pii: S1473-3099(21)00205.
    >> Share

  98. THOMPSON RN, Hill EM, Gog JR
    SARS-CoV-2 incidence and vaccine escape.
    Lancet Infect Dis. 2021 Apr 13. pii: S1473-3099(21)00202.
    >> Share

  99. BOUM Y, Eyangoh S, Okomo MC
    Beyond COVID-19-will self-sampling and testing become the norm?
    Lancet Infect Dis. 2021 Apr 12. pii: S1473-3099(21)00197.
    >> Share

  100. ONG SWX, Young BE, Lye DC
    Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomes.
    Lancet Infect Dis. 2021 Apr 12. pii: S1473-3099(21)00201.
    >> Share

  101. FRAMPTON D, Rampling T, Cross A, Bailey H, et al
    Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.
    Lancet Infect Dis. 2021 Apr 12. pii: S1473-3099(21)00170.
    >> Share

  102. TSANG NNY, So HC, Ng KY, Cowling BJ, et al
    Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis.
    Lancet Infect Dis. 2021 Apr 12. pii: S1473-3099(21)00146.
    >> Share

  103. THE LANCET INFECTIOUS DISEASES
    "In an ocean of ashes, islands of order": WHO's SARS-CoV-2 origin report.
    Lancet Infect Dis. 2021 Apr 9. pii: S1473-3099(21)00213.
    >> Share

  104. HOLT E
    COVID-19 vaccination in Ukraine.
    Lancet Infect Dis. 2021;21:462.
    >> Share

  105. ADEPOJU P
    Ebola and COVID-19 in DR Congo and Guinea.
    Lancet Infect Dis. 2021;21:461.
    >> Share

  106. BURKI T
    Behind Cuba's successful pandemic response.
    Lancet Infect Dis. 2021;21:465-466.
    >> Share

  107. KENYON G
    Vacuna-gate escalates in Peru.
    Lancet Infect Dis. 2021;21:463.
    >> Share

  108. THE LANCET INFECTIOUS DISEASES
    A glimmer of hope beyond the spring for Europe.
    Lancet Infect Dis. 2021;21:439.
    >> Share

  109. JOMBART T
    Why development of outbreak analytics tools should be valued, supported, and funded.
    Lancet Infect Dis. 2021;21:458-459.
    >> Share

    March 2021
  110. JENTSCH PC, Anand M, Bauch CT
    Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study.
    Lancet Infect Dis. 2021 Mar 31. pii: S1473-3099(21)00057.
    >> Share

  111. WELLS CR, Galvani AP
    The interplay between COVID-19 restrictions and vaccination.
    Lancet Infect Dis. 2021 Mar 31. pii: S1473-3099(21)00074.
    >> Share

  112. MAHARAJ AS, Parker J, Hopkins JP, Gournis E, et al
    The effect of seasonal respiratory virus transmission on syndromic surveillance for COVID-19 in Ontario, Canada.
    Lancet Infect Dis. 2021 Mar 25. pii: S1473-3099(21)00151.
    >> Share

  113. BOUM Y, Fai KN, Nicolay B, Mboringong AB, et al
    Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study.
    Lancet Infect Dis. 2021 Mar 25. pii: S1473-3099(21)00132.
    >> Share

  114. PEELING RW, Olliaro P
    Rolling out COVID-19 antigen rapid diagnostic tests: the time is now.
    Lancet Infect Dis. 2021 Mar 25. pii: S1473-3099(21)00152.
    >> Share

  115. IVERSEN PL, Bavari S
    Is there space for a three-dose vaccine to fight the spread of SARS-CoV-2?
    Lancet Infect Dis. 2021 Mar 24. pii: S1473-3099(21)00149.
    >> Share

  116. YANG S, Li Y, Dai L, Wang J, et al
    Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
    Lancet Infect Dis. 2021 Mar 24. pii: S1473-3099(21)00127.
    >> Share

  117. KIANG MV, Chin ET, Huynh BQ, Chapman LAC, et al
    Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study.
    Lancet Infect Dis. 2021 Mar 22. pii: S1473-3099(21)00134.
    >> Share

  118. GUILAMO-RAMOS V, Thimm-Kaiser M, Benzekri A, Hidalgo A, et al
    Nurses at the frontline of public health emergency preparedness and response: lessons learned from the HIV/AIDS pandemic and emerging infectious disease outbreaks.
    Lancet Infect Dis. 2021 Mar 18. pii: S1473-3099(20)30983.
    >> Share

  119. MACINTYRE CR
    Navigating post-vaccine COVID-19 futures in the health and economic context.
    Lancet Infect Dis. 2021 Mar 18. pii: S1473-3099(21)00126.
    >> Share

  120. CONTRERAS S, Priesemann V
    Risking further COVID-19 waves despite vaccination.
    Lancet Infect Dis. 2021 Mar 18. pii: S1473-3099(21)00167.
    >> Share

  121. MOORE S, Hill EM, Tildesley MJ, Dyson L, et al
    Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.
    Lancet Infect Dis. 2021 Mar 18. pii: S1473-3099(21)00143.
    >> Share

  122. SANDMANN FG, Davies NG, Vassall A, Edmunds WJ, et al
    The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.
    Lancet Infect Dis. 2021 Mar 18. pii: S1473-3099(21)00079.
    >> Share

  123. NICOLAS D, Coloma E, Pericas JM
    Alternatives to conventional hospitalisation that enhance health systems' capacity to treat COVID-19.
    Lancet Infect Dis. 2021 Mar 9. pii: S1473-3099(21)00093.
    >> Share

  124. VAN GEMERT C, Tapo PS, Sero K
    Border screening is an essential component of COVID-19 testing strategies in Vanuatu.
    Lancet Infect Dis. 2021 Mar 8. pii: S1473-3099(21)00135.
    >> Share

  125. ELLA R, Reddy S, Jogdand H, Sarangi V, et al
    Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial.
    Lancet Infect Dis. 2021 Mar 8. pii: S1473-3099(21)00070.
    >> Share

  126. LI JX, Zhu FC
    Adjuvantation helps to optimise COVID-19 vaccine candidate.
    Lancet Infect Dis. 2021 Mar 8. pii: S1473-3099(21)00094.
    >> Share

  127. MEHTA P, Bunker CB, Ciurtin C, Porter JC, et al
    Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy.
    Lancet Infect Dis. 2021 Mar 8. pii: S1473-3099(21)00133.
    >> Share

  128. VAN DIJCK C, Tsoumanis A, Rotsaert A, Vuylsteke B, et al
    Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial.
    Lancet Infect Dis. 2021 Mar 4. pii: S1473-3099(20)30778.
    >> Share

  129. BURKI T
    COVID-19 among American Indians and Alaska Natives.
    Lancet Infect Dis. 2021;21:325-326.
    >> Share

  130. SAMARASEKERA U
    Feelings towards COVID-19 vaccination in Africa.
    Lancet Infect Dis. 2021;21:324.
    >> Share

  131. BAGCCHI S
    The world's largest COVID-19 vaccination campaign.
    Lancet Infect Dis. 2021;21:323.
    >> Share

  132. PERMPALUNG N, Maertens J, Marr KA
    Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis.
    Lancet Infect Dis. 2021 Mar 1. pii: S1473-3099(21)00060.
    >> Share

  133. JABEEN K, Farooqi J, Irfan M, Ali SA, et al
    Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis.
    Lancet Infect Dis. 2021 Mar 1. pii: S1473-3099(21)00066.
    >> Share

  134. DROZD M, Pujades-Rodriguez M, Lillie PJ, Straw S, et al
    Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study.
    Lancet Infect Dis. 2021 Mar 1. pii: S1473-3099(20)30978.
    >> Share

  135. KOEHLER P, White PL, Verweij PE, Cornely OA, et al
    Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis - Authors' reply.
    Lancet Infect Dis. 2021 Mar 1. pii: S1473-3099(21)00123.
    >> Share

  136. TARANTOLA A, Gautier L
    Biostatistics to better detect fishy findings.
    Lancet Infect Dis. 2021;21:316-317.
    >> Share

    February 2021
  137. OZONOFF A, Nanishi E, Levy O
    Bell's palsy and SARS-CoV-2 vaccines.
    Lancet Infect Dis. 2021 Feb 24. pii: S1473-3099(21)00076.
    >> Share

  138. DARMON M, Dumas G
    Anticipating outcomes for patients with COVID-19 and identifying prognosis patterns.
    Lancet Infect Dis. 2021 Feb 23. pii: S1473-3099(21)00073.
    >> Share

  139. PEELING RW, Olliaro PL, Boeras DI, Fongwen N, et al
    Scaling up COVID-19 rapid antigen tests: promises and challenges.
    Lancet Infect Dis. 2021 Feb 23. pii: S1473-3099(21)00048.
    >> Share

  140. GUTIERREZ-GUTIERREZ B, Del Toro MD, Borobia AM, Carcas A, et al
    Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study.
    Lancet Infect Dis. 2021 Feb 23. pii: S1473-3099(21)00019.
    >> Share

  141. SPINELLI MA, Glidden DV, Gennatas ED, Bielecki M, et al
    Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity.
    Lancet Infect Dis. 2021 Feb 22. pii: S1473-3099(20)30982.
    >> Share

  142. OLLIARO P
    What does 95% COVID-19 vaccine efficacy really mean?
    Lancet Infect Dis. 2021 Feb 17. pii: S1473-3099(21)00075.
    >> Share

  143. ROMERO C, Diez JM, Gajardo R
    Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products.
    Lancet Infect Dis. 2021 Feb 16. pii: S1473-3099(21)00059.
    >> Share

  144. GHAFARI M, Kadivar A, Katzourakis A
    Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran.
    Lancet Infect Dis. 2021 Feb 15. pii: S1473-3099(21)00053.
    >> Share

  145. NAZEMIPOUR M, Shakiba M, Mansournia MA
    Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran.
    Lancet Infect Dis. 2021 Feb 15. pii: S1473-3099(21)00044.
    >> Share

  146. DARVISHIAN M, Sharafkhah M, Poustchi H, Malekzadeh R, et al
    Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran - Authors' reply.
    Lancet Infect Dis. 2021 Feb 15. pii: S1473-3099(21)00058.
    >> Share

  147. INZAULE SC, Tessema SK, Kebede Y, Ogwell Ouma AE, et al
    Genomic-informed pathogen surveillance in Africa: opportunities and challenges.
    Lancet Infect Dis. 2021 Feb 12. pii: S1473-3099(20)30939.
    >> Share

  148. THE LANCET INFECTIOUS DISEASES
    The COVID-19 exit strategy-why we need to aim low.
    Lancet Infect Dis. 2021 Feb 11. pii: S1473-3099(21)00080.
    >> Share

  149. ALAM I, Radovanovic A, Incitti R, Kamau AA, et al
    CovMT: an interactive SARS-CoV-2 mutation tracker, with a focus on critical variants.
    Lancet Infect Dis. 2021 Feb 8. pii: S1473-3099(21)00078.
    >> Share

  150. IVERSEN PL, Bavari S
    Inactivated COVID-19 vaccines to make a global impact.
    Lancet Infect Dis. 2021 Feb 3. pii: S1473-3099(21)00020.
    >> Share

  151. FAIRGRIEVE D, Holm S, Howells G, Kirchhelle C, et al
    In favour of a bespoke COVID-19 vaccines compensation scheme.
    Lancet Infect Dis. 2021 Feb 3. pii: S1473-3099(21)00065.
    >> Share

  152. WU Z, Hu Y, Xu M, Chen Z, et al
    Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
    Lancet Infect Dis. 2021 Feb 3. pii: S1473-3099(20)30987.
    >> Share

  153. CORNELISSEN L, Andre E
    Understanding the drivers of transmission of SARS-CoV-2.
    Lancet Infect Dis. 2021 Feb 2. pii: S1473-3099(21)00005.
    >> Share

  154. MARKS M, Millat-Martinez P, Ouchi D, Roberts CH, et al
    Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study.
    Lancet Infect Dis. 2021 Feb 2. pii: S1473-3099(20)30985.
    >> Share

  155. STRINGHINI S, Zaballa ME, Perez-Saez J, Pullen N, et al
    Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak.
    Lancet Infect Dis. 2021 Feb 1. pii: S1473-3099(21)00054.
    >> Share

  156. BURKI T
    The elusive elimination of river blindness.
    Lancet Infect Dis. 2021;21:175-176.
    >> Share

  157. MAKONI M
    New tuberculosis tests and drugs remain out of reach.
    Lancet Infect Dis. 2021;21:174.
    >> Share

  158. THE LANCET INFECTIOUS DISEASES
    An exceptional vaccination policy in exceptional circumstances.
    Lancet Infect Dis. 2021;21:149.
    >> Share

  159. MANTHA S
    Ratio, rate, or risk?
    Lancet Infect Dis. 2021;21:165-166.
    >> Share

  160. BAUCH CT
    Estimating the COVID-19 R number: a bargain with the devil?
    Lancet Infect Dis. 2021;21:151-153.
    >> Share

  161. LI Y, Campbell H, Kulkarni D, Harpur A, et al
    The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries.
    Lancet Infect Dis. 2021;21:193-202.
    >> Share

    January 2021
  162. MOHAPATRA PR, Mishra B
    Regulatory approval of COVID-19 vaccine for restricted use in clinical trial mode.
    Lancet Infect Dis. 2021 Jan 25. pii: S1473-3099(21)00045.
    >> Share

  163. ELLA R, Vadrevu KM, Jogdand H, Prasad S, et al
    Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial.
    Lancet Infect Dis. 2021 Jan 21. pii: S1473-3099(20)30942.
    >> Share

  164. ROSTAD CA, Anderson EJ
    Optimism and caution for an inactivated COVID-19 vaccine.
    Lancet Infect Dis. 2021 Jan 21. pii: S1473-3099(20)30988.
    >> Share

  165. PALLETT SJC, Jones R, Randell P, Davies GW, et al
    Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection.
    Lancet Infect Dis. 2021 Jan 20. pii: S1473-3099(20)30990.
    >> Share

  166. GARDNER AR
    COVID-19 through the Latinx infectious disease doctor's eyes.
    Lancet Infect Dis. 2021 Jan 19. pii: S1473-3099(20)30885.
    >> Share

  167. LI F, Li YY, Liu MJ, Fang LQ, et al
    Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study.
    Lancet Infect Dis. 2021 Jan 18. pii: S1473-3099(20)30981.
    >> Share

  168. MCMAHON DE, Gallman AE, Hruza GJ, Rosenbach M, et al
    Long COVID in the skin: a registry analysis of COVID-19 dermatological duration.
    Lancet Infect Dis. 2021 Jan 15. pii: S1473-3099(20)30986.
    >> Share

  169. JARCHOW-MACDONALD AA, Burns R, Miller J, Kerr L, et al
    Keeping childhood immunisation rates stable during the COVID-19 pandemic.
    Lancet Infect Dis. 2021 Jan 15. pii: S1473-3099(20)30991.
    >> Share

  170. FIORENTINI S, Messali S, Zani A, Caccuri F, et al
    First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020.
    Lancet Infect Dis. 2021 Jan 12. pii: S1473-3099(21)00007.
    >> Share

  171. ROTHE C
    Multiple testing and the effect of NPIs on the spread of SARS-CoV-2.
    Lancet Infect Dis. 2021 Jan 6. pii: S1473-3099(20)30935.
    >> Share

  172. BURKI T
    Equitable distribution of COVID-19 vaccines.
    Lancet Infect Dis. 2021;21:33-34.
    >> Share

  173. HOLT E
    COVID-19 testing in Slovakia.
    Lancet Infect Dis. 2021;21:32.
    >> Share

  174. THE LANCET INFECTIOUS DISEASES
    Tuberculosis and malaria in the age of COVID-19.
    Lancet Infect Dis. 2021;21:1.
    >> Share

    December 2020
  175. DAVIES NG, Barnard RC, Jarvis CI, Russell TW, et al
    Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling study.
    Lancet Infect Dis. 2020 Dec 23. pii: S1473-3099(20)30984.
    >> Share

  176. HENGEL B, Causer L, Matthews S, Smith K, et al
    A decentralised point-of-care testing model to address inequities in the COVID-19 response.
    Lancet Infect Dis. 2020 Dec 23. pii: S1473-3099(20)30859.
    >> Share

  177. SAMER C, Lacombe K, Calmy A
    Cyber harassment of female scientists will not be the new norm.
    Lancet Infect Dis. 2020 Dec 23. pii: S1473-3099(20)30944.
    >> Share

  178. DUYSBURGH E, Mortgat L, Barbezange C, Dierick K, et al
    Persistence of IgG response to SARS-CoV-2.
    Lancet Infect Dis. 2020 Dec 17. pii: S1473-3099(20)30943.
    >> Share

  179. POUSTCHI H, Darvishian M, Mohammadi Z, Shayanrad A, et al
    SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Lancet Infect Dis. 2020 Dec 15. pii: S1473-3099(20)30858.
    >> Share

  180. DODD RH, Pickles K, Nickel B, Cvejic E, et al
    Concerns and motivations about COVID-19 vaccination.
    Lancet Infect Dis. 2020 Dec 15. pii: S1473-3099(20)30926.
    >> Share

  181. KOEHLER P, Bassetti M, Chakrabarti A, Chen SCA, et al
    Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
    Lancet Infect Dis. 2020 Dec 14. pii: S1473-3099(20)30847.
    >> Share

  182. ALLISON J, Badanjak S, Bach B, Bell C, et al
    An interactive tracker for ceasefires in the time of COVID-19.
    Lancet Infect Dis. 2020 Dec 14. pii: S1473-3099(20)30932.
    >> Share

  183. FLASCHE S, Edmunds WJ
    The role of schools and school-aged children in SARS-CoV-2 transmission.
    Lancet Infect Dis. 2020 Dec 8. pii: S1473-3099(20)30927.
    >> Share

  184. ISMAIL SA, Saliba V, Lopez Bernal J, Ramsay ME, et al
    SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England.
    Lancet Infect Dis. 2020 Dec 8. pii: S1473-3099(20)30882.
    >> Share

  185. SINGH JA, Upshur REG
    The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials.
    Lancet Infect Dis. 2020 Dec 8. pii: S1473-3099(20)30923.
    >> Share

  186. MARSHALL JC, Murthy S, Diaz J
    Fungal infections should be part of the core outcome set for COVID-19 - Authors' reply.
    Lancet Infect Dis. 2020 Dec 7. pii: S1473-3099(20)30681.
    >> Share

  187. VERWEIJ PE, Alanio A
    Fungal infections should be part of the core outcome set for COVID-19.
    Lancet Infect Dis. 2020 Dec 7. pii: S1473-3099(20)30591.
    >> Share

  188. BROWN RCH, Savulescu J, Kelly D, Wilkinson D, et al
    A public health ethic should inform policies on COVID-19 immunity passports - Authors' reply.
    Lancet Infect Dis. 2020 Dec 7. pii: S1473-3099(20)30922.
    >> Share

  189. BAYLIS F, Kofler N
    A public health ethic should inform policies on COVID-19 immunity passports.
    Lancet Infect Dis. 2020 Dec 7. pii: S1473-3099(20)30918.
    >> Share

  190. MEYEROWITZ EA, Richterman A, Bogoch II, Low N, et al
    Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2.
    Lancet Infect Dis. 2020 Dec 7. pii: S1473-3099(20)30837.
    >> Share

  191. ARMITAGE R, Nellums LB
    Antibiotic prescribing in general practice during COVID-19.
    Lancet Infect Dis. 2020 Dec 1. pii: S1473-3099(20)30917.
    >> Share

  192. KAZI F, Mushtaq A
    IDWeek 2020.
    Lancet Infect Dis. 2020;20:1374.
    >> Share

    November 2020
  193. YOUNG B, Tan TT, Leo YS
    The place for remdesivir in COVID-19 treatment.
    Lancet Infect Dis. 2020 Nov 26. pii: S1473-3099(20)30911.
    >> Share

  194. PRADO-VIVAR B, Becerra-Wong M, Guadalupe JJ, Marquez S, et al
    A case of SARS-CoV-2 reinfection in Ecuador.
    Lancet Infect Dis. 2020 Nov 23. pii: S1473-3099(20)30910.
    >> Share

  195. KOOPMANS M
    SARS-CoV-2 and the human-animal interface: outbreaks on mink farms.
    Lancet Infect Dis. 2020 Nov 20. pii: S1473-3099(20)30912.
    >> Share

  196. KAMPF G, Lemmen S, Suchomel M
    Ct values and infectivity of SARS-CoV-2 on surfaces.
    Lancet Infect Dis. 2020 Nov 19. pii: S1473-3099(20)30883.
    >> Share

  197. ROARTY C, Tonry C, McFetridge L, Mitchell H, et al
    Kinetics and seroprevalence of SARS-CoV-2 antibodies in children.
    Lancet Infect Dis. 2020 Nov 19. pii: S1473-3099(20)30884.
    >> Share

  198. BAR-ZEEV N, Kochhar S
    Expecting the unexpected with COVID-19 vaccines.
    Lancet Infect Dis. 2020 Nov 17. pii: S1473-3099(20)30870.
    >> Share

  199. ZHANG Y, Zeng G, Pan H, Li C, et al
    Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
    Lancet Infect Dis. 2020 Nov 17. pii: S1473-3099(20)30843.
    >> Share

  200. PEIFFER-SMADJA N, Rebeaud ME, Guihur A, Mahamat-Saleh Y, et al
    Hydroxychloroquine and COVID-19: a tale of populism and obscurantism.
    Lancet Infect Dis. 2020 Nov 13. pii: S1473-3099(20)30866.
    >> Share

  201. NG OT, Marimuthu K, Koh V, Pang J, et al
    SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.
    Lancet Infect Dis. 2020 Nov 2. pii: S1473-3099(20)30833.
    >> Share

  202. BADR HS, Gardner LM
    Limitations of using mobile phone data to model COVID-19 transmission in the USA.
    Lancet Infect Dis. 2020 Nov 2. pii: S1473-3099(20)30861.
    >> Share

  203. KIRBY T
    Matshidiso Moeti, first female WHO Regional Director.
    Lancet Infect Dis. 2020;20:1244.
    >> Share

  204. MUSHTAQ A, Kazi F
    New guidelines to treat bacterial infections.
    Lancet Infect Dis. 2020;20:1239.
    >> Share

  205. JESUDASON T
    The 11th annual NTD NGO Network conference.
    Lancet Infect Dis. 2020;20:1238.
    >> Share

    October 2020
  206. IVERSEN K, Bundgaard H, Harritshoj L, Ullum H, et al
    Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies - Authors' reply.
    Lancet Infect Dis. 2020 Oct 30. pii: S1473-3099(20)30849.
    >> Share

  207. CHOY KW
    Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies.
    Lancet Infect Dis. 2020 Oct 30. pii: S1473-3099(20)30787.
    >> Share

  208. VAN ELSLANDE J, Andre E, Van Ranst M, Lagrou K, et al
    Immunoassays for anti-SARS-CoV-2 antibodies: recent insights.
    Lancet Infect Dis. 2020 Oct 30. pii: S1473-3099(20)30846.
    >> Share

  209. HODGSON SH, Mansatta K, Mallett G, Harris V, et al
    What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2.
    Lancet Infect Dis. 2020 Oct 27. pii: S1473-3099(20)30773.
    >> Share

  210. YANG W, Kandula S, Huynh M, Greene SK, et al
    Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
    Lancet Infect Dis. 2020 Oct 19. pii: S1473-3099(20)30769.
    >> Share

  211. BROWN RCH, Kelly D, Wilkinson D, Savulescu J, et al
    The scientific and ethical feasibility of immunity passports.
    Lancet Infect Dis. 2020 Oct 16. pii: S1473-3099(20)30766.
    >> Share

  212. ISAKOVA-SIVAK I, Rudenko L
    A promising inactivated whole-virion SARS-CoV-2 vaccine.
    Lancet Infect Dis. 2020 Oct 15. pii: S1473-3099(20)30832.
    >> Share

  213. XIA S, Zhang Y, Wang Y, Wang H, et al
    Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
    Lancet Infect Dis. 2020 Oct 15. pii: S1473-3099(20)30831.
    >> Share

  214. TILLETT RL, Sevinsky JR, Hartley PD, Kerwin H, et al
    Genomic evidence for reinfection with SARS-CoV-2: a case study.
    Lancet Infect Dis. 2020 Oct 12. pii: S1473-3099(20)30764.
    >> Share

  215. IWASAKI A
    What reinfections mean for COVID-19.
    Lancet Infect Dis. 2020 Oct 12. pii: S1473-3099(20)30783.
    >> Share

  216. VEHRESCHILD MJGT, Tacconelli E, Giske CG, Peschel A, et al
    Beyond COVID-19-a paradigm shift in infection management?
    Lancet Infect Dis. 2020 Oct 9. pii: S1473-3099(20)30789.
    >> Share

  217. THE LANCET INFECTIOUS DISEASES
    The intersection of COVID-19 and mental health.
    Lancet Infect Dis. 2020 Oct 8. pii: S1473-3099(20)30797.
    >> Share

  218. BURKI T
    China's successful control of COVID-19.
    Lancet Infect Dis. 2020 Oct 8. pii: S1473-3099(20)30800.
    >> Share

  219. PERLMAN S, Zumla A
    MERS-CoV in Africa-an enigma with relevance to COVID-19.
    Lancet Infect Dis. 2020 Oct 6. pii: S1473-3099(20)30578.
    >> Share

  220. MOK CKP, Zhu A, Zhao J, Lau EHY, et al
    T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort study.
    Lancet Infect Dis. 2020 Oct 6. pii: S1473-3099(20)30599.
    >> Share

  221. KHALIL A, von Dadelszen P, Kalafat E, Sebghati M, et al
    Change in obstetric attendance and activities during the COVID-19 pandemic.
    Lancet Infect Dis. 2020 Oct 5. pii: S1473-3099(20)30779.
    >> Share

  222. GALVAO J
    COVID-19: the deadly threat of misinformation.
    Lancet Infect Dis. 2020 Oct 5. pii: S1473-3099(20)30721.
    >> Share

  223. BURKI T
    COVID-19 claims another victim.
    Lancet Infect Dis. 2020;20:1129-1130.
    >> Share

  224. MAKONI M
    COVID-19 in Africa: half a year later.
    Lancet Infect Dis. 2020;20:1127.
    >> Share

  225. RATHI S, Ish P, Kalantri A, Kalantri S, et al
    Hydroxychloroquine prophylaxis for COVID-19 contacts in India.
    Lancet Infect Dis. 2020;20:1118-1119.
    >> Share

  226. PRINCIPI N, Esposito S
    Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.
    Lancet Infect Dis. 2020;20:1118.
    >> Share

  227. KIRBY T
    Evelina Tacconelli-two viruses, two wars.
    Lancet Infect Dis. 2020;20:1132.
    >> Share

  228. BALAKRISHNAN VS
    The arrival of Sputnik V.
    Lancet Infect Dis. 2020;20:1128.
    >> Share

    September 2020
  229. FRANCO-PAREDES C, Ghandnoosh N, Latif H, Krsak M, et al
    Decarceration and community re-entry in the COVID-19 era.
    Lancet Infect Dis. 2020 Sep 29. pii: S1473-3099(20)30730.
    >> Share

  230. MONDELLI MU, Colaneri M, Seminari EM, Baldanti F, et al
    Low risk of SARS-CoV-2 transmission by fomites in real-life conditions.
    Lancet Infect Dis. 2020 Sep 29. pii: S1473-3099(20)30678.
    >> Share


  231. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.
    Lancet Infect Dis. 2020 Sep 23. pii: S1473-3099(20)30634.
    >> Share

  232. HOULIHAN CF, Beale R
    The complexities of SARS-CoV-2 serology.
    Lancet Infect Dis. 2020 Sep 23. pii: S1473-3099(20)30699.
    >> Share

  233. TEBOH-EWUNGKEM MI, Ngwa GA
    COVID-19 in malaria-endemic regions: potential consequences for malaria intervention coverage, morbidity, and mortality.
    Lancet Infect Dis. 2020 Sep 21. pii: S1473-3099(20)30763.
    >> Share

  234. WEISS DJ, Bertozzi-Villa A, Rumisha SF, Amratia P, et al
    Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis.
    Lancet Infect Dis. 2020 Sep 21. pii: S1473-3099(20)30700.
    >> Share

  235. GATALO O, Tseng K, Hamilton A, Lin G, et al
    Associations between phone mobility data and COVID-19 cases.
    Lancet Infect Dis. 2020 Sep 15. pii: S1473-3099(20)30725.
    >> Share

  236. RHODES A, Hoq M, Measey MA, Danchin M, et al
    Intention to vaccinate against COVID-19 in Australia.
    Lancet Infect Dis. 2020 Sep 14. pii: S1473-3099(20)30724.
    >> Share

  237. BAX A, Bax CE, Stadnytskyi V, Anfinrud P, et al
    SARS-CoV-2 transmission via speech-generated respiratory droplets.
    Lancet Infect Dis. 2020 Sep 11. pii: S1473-3099(20)30726.
    >> Share

  238. THE LANCET INFECTIOUS DISEASES
    Curing COVID-19.
    Lancet Infect Dis. 2020 Sep 10. pii: S1473-3099(20)30706.
    >> Share

  239. THE LANCET INFECTIOUS DISEASES
    Air travel in the time of COVID-19.
    Lancet Infect Dis. 2020;20:993.
    >> Share

  240. BURKI T
    The origin of SARS-CoV-2.
    Lancet Infect Dis. 2020;20:1018-1019.
    >> Share

  241. YELIN D, Wirtheim E, Vetter P, Kalil AC, et al
    Long-term consequences of COVID-19: research needs.
    Lancet Infect Dis. 2020 Sep 1. pii: S1473-3099(20)30701.
    >> Share

    August 2020
  242. GRASSLY NC, Pons-Salort M, Parker EPK, White PJ, et al
    Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study.
    Lancet Infect Dis. 2020 Aug 18. pii: S1473-3099(20)30630.
    >> Share

  243. JIANG L, Tang K, Levin M, Irfan O, et al
    COVID-19 and multisystem inflammatory syndrome in children and adolescents.
    Lancet Infect Dis. 2020 Aug 17. pii: S1473-3099(20)30651.
    >> Share

  244. JAVELLE E, Raoult D
    COVID-19 pandemic more than a century after the Spanish flu.
    Lancet Infect Dis. 2020 Aug 11. pii: S1473-3099(20)30650.
    >> Share

  245. HEATH PT, Le Doare K, Khalil A
    Inclusion of pregnant women in COVID-19 vaccine development.
    Lancet Infect Dis. 2020 Aug 11. pii: S1473-3099(20)30638.
    >> Share

  246. MANHEIM D
    Evolving ethics of COVID-19 challenge trials.
    Lancet Infect Dis. 2020 Aug 11. pii: S1473-3099(20)30649.
    >> Share

  247. STANDL F, Jockel KH, Brune B, Schmidt B, et al
    Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.
    Lancet Infect Dis. 2020 Aug 11. pii: S1473-3099(20)30648.
    >> Share

  248. GARDNER L, Ratcliff J, Dong E, Katz A, et al
    A need for open public data standards and sharing in light of COVID-19.
    Lancet Infect Dis. 2020 Aug 10. pii: S1473-3099(20)30635.
    >> Share

  249. EPSTEIN JB, Chow K, Mathias R
    Dental procedure aerosols and COVID-19.
    Lancet Infect Dis. 2020 Aug 10. pii: S1473-3099(20)30636.
    >> Share

  250. KALK A, Schultz A
    SARS-CoV-2 epidemic in African countries-are we losing perspective?
    Lancet Infect Dis. 2020 Aug 7. pii: S1473-3099(20)30563.
    >> Share

  251. HEYWOOD AE, Macintyre CR
    Elimination of COVID-19: what would it look like and is it possible?
    Lancet Infect Dis. 2020 Aug 6. pii: S1473-3099(20)30633.
    >> Share

  252. ARORA RK, Joseph A, Van Wyk J, Rocco S, et al
    SeroTracker: a global SARS-CoV-2 seroprevalence dashboard.
    Lancet Infect Dis. 2020 Aug 4. pii: S1473-3099(20)30631.
    >> Share

  253. JOY M, Hobbs FDR, McGagh D, Akinyemi O, et al
    Excess mortality from COVID-19 in an English sentinel network population.
    Lancet Infect Dis. 2020 Aug 4. pii: S1473-3099(20)30632.
    >> Share

  254. IVERSEN K, Bundgaard H, Hasselbalch RB, Kristensen JH, et al
    Risk of COVID-19 in health-care workers in Denmark: an observational cohort study.
    Lancet Infect Dis. 2020 Aug 3. pii: S1473-3099(20)30589.
    >> Share

  255. KUCHARSKI AJ, Nilles EJ
    Using serological data to understand unobserved SARS-CoV-2 risk in health-care settings.
    Lancet Infect Dis. 2020 Aug 3. pii: S1473-3099(20)30579.
    >> Share

  256. BURKI T
    The indirect impact of COVID-19 on women.
    Lancet Infect Dis. 2020;20:904-905.
    >> Share

  257. JESUDASON T
    New WHO road map for NTD recovery post COVID-19.
    Lancet Infect Dis. 2020;20:902.
    >> Share

  258. KIRBY T
    Annelies Wilder-Smith.
    Lancet Infect Dis. 2020;20:907.
    >> Share

  259. BARBER S
    Death by racism.
    Lancet Infect Dis. 2020;20:903.
    >> Share

    July 2020
  260. DAWOOD FS, Ricks P, Njie GJ, Daugherty M, et al
    Observations of the global epidemiology of COVID-19 from the prepandemic period using web-based surveillance: a cross-sectional analysis.
    Lancet Infect Dis. 2020 Jul 29. pii: S1473-3099(20)30581.
    >> Share

  261. GRILLO F, Barisione E, Ball L, Mastracci L, et al
    Lung fibrosis: an undervalued finding in COVID-19 pathological series.
    Lancet Infect Dis. 2020 Jul 28. pii: S1473-3099(20)30582.
    >> Share

  262. PEELING RW, Boeras D, Wilder-Smith A, Sall A, et al
    Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential.
    Lancet Infect Dis. 2020 Jul 24. pii: S1473-3099(20)30461.
    >> Share

  263. BIELICKI JA, Duval X, Gobat N, Goossens H, et al
    Monitoring approaches for health-care workers during the COVID-19 pandemic.
    Lancet Infect Dis. 2020 Jul 23. pii: S1473-3099(20)30458.
    >> Share

  264. THE LANCET INFECTIOUS DISEASES
    The COVID-19 infodemic.
    Lancet Infect Dis. 2020 Jul 17. pii: S1473-3099(20)30565.
    >> Share

  265. COOK M
    Potential factors linked to high COVID-19 death rates in British minority ethnic groups.
    Lancet Infect Dis. 2020 Jul 17. pii: S1473-3099(20)30583.
    >> Share

  266. PEELING RW, Wedderburn CJ, Garcia PJ, Boeras D, et al
    Serology testing in the COVID-19 pandemic response.
    Lancet Infect Dis. 2020 Jul 17. pii: S1473-3099(20)30517.
    >> Share

  267. EBERHARDT JN, Breuckmann NP, Eberhardt CS
    Challenges and issues of SARS-CoV-2 pool testing.
    Lancet Infect Dis. 2020 Jul 14. pii: S1473-3099(20)30467.
    >> Share

  268. BEHRMANN O, Spiegel M
    COVID-19: from rapid genome sequencing to fast decisions.
    Lancet Infect Dis. 2020 Jul 14. pii: S1473-3099(20)30580.
    >> Share

  269. LOHSE S, Pfuhl T, Berko-Gottel B, Gartner B, et al
    Challenges and issues of SARS-CoV-2 pool testing - Authors' reply.
    Lancet Infect Dis. 2020 Jul 14. pii: S1473-3099(20)30455.
    >> Share

  270. PEREZ-SAEZ J, Lauer SA, Kaiser L, Regard S, et al
    Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland.
    Lancet Infect Dis. 2020 Jul 14. pii: S1473-3099(20)30584.
    >> Share

  271. MISHRA B, Behera B, Mohanty M, Ravindra A, et al
    Challenges and issues of SARS-CoV-2 pool testing.
    Lancet Infect Dis. 2020 Jul 14. pii: S1473-3099(20)30463.
    >> Share

  272. MEREDITH LW, Hamilton WL, Warne B, Houldcroft CJ, et al
    Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study.
    Lancet Infect Dis. 2020 Jul 14. pii: S1473-3099(20)30562.
    >> Share

  273. LEE J, Kim SY, Sung H, Lee SW, et al
    Challenges and issues of SARS-CoV-2 pool testing.
    Lancet Infect Dis. 2020 Jul 14. pii: S1473-3099(20)30516.
    >> Share

  274. MEI Q, Li J, Du R, Yuan X, et al
    Assessment of patients who tested positive for COVID-19 after recovery.
    Lancet Infect Dis. 2020 Jul 6. pii: S1473-3099(20)30433.
    >> Share

  275. GOLDMAN E
    Exaggerated risk of transmission of COVID-19 by fomites.
    Lancet Infect Dis. 2020 Jul 3. pii: S1473-3099(20)30561.
    >> Share

  276. HOXHA A, Wyndham-Thomas C, Klamer S, Dubourg D, et al
    Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities.
    Lancet Infect Dis. 2020 Jul 3. pii: S1473-3099(20)30560.
    >> Share

  277. PETERSEN E, Koopmans M, Go U, Hamer DH, et al
    Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.
    Lancet Infect Dis. 2020 Jul 3. pii: S1473-3099(20)30484.
    >> Share

  278. SIKKEMA RS, Pas SD, Nieuwenhuijse DF, O'Toole A, et al
    COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study.
    Lancet Infect Dis. 2020 Jul 2. pii: S1473-3099(20)30527.
    >> Share

  279. BALAKRISHNAN VS
    COVID-19: Playing away the pandemic.
    Lancet Infect Dis. 2020;20:792.
    >> Share

  280. VENKATESAN P
    COVID-19 in Iran: round 2.
    Lancet Infect Dis. 2020;20:784.
    >> Share

  281. TRIUNFOL M
    High COVID-19 testing rate in Portugal.
    Lancet Infect Dis. 2020;20:783.
    >> Share

  282. BAGCCHI S
    Stigma during the COVID-19 pandemic.
    Lancet Infect Dis. 2020;20:782.
    >> Share

  283. BADR HS, Du H, Marshall M, Dong E, et al
    Association between mobility patterns and COVID-19 transmission in the USA: a mathematical modelling study.
    Lancet Infect Dis. 2020 Jul 1. pii: S1473-3099(20)30553.
    >> Share

  284. AZMAN AS, Luquero FJ
    From China: hope and lessons for COVID-19 control.
    Lancet Infect Dis. 2020;20:756-757.
    >> Share

  285. ZHANG J, Litvinova M, Wang W, Wang Y, et al
    Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study.
    Lancet Infect Dis. 2020;20:793-802.
    >> Share

  286. JIA Z, Lu Z
    Modelling COVID-19 transmission: from data to intervention.
    Lancet Infect Dis. 2020;20:757-758.
    >> Share

  287. NIEHUS R, De Salazar PM, Taylor AR, Lipsitch M, et al
    Using observational data to quantify bias of traveller-derived COVID-19 prevalence estimates in Wuhan, China.
    Lancet Infect Dis. 2020;20:803-808.
    >> Share

  288. AHMED H, Allaf M, Elghazaly H
    COVID-19 and medical education.
    Lancet Infect Dis. 2020;20:777-778.
    >> Share

  289. BAUD D, Nielsen-Saines K, Qi X, Musso D, et al
    Authors' reply.
    Lancet Infect Dis. 2020;20:775-776.
    >> Share

  290. BURKI T
    Global shortage of personal protective equipment.
    Lancet Infect Dis. 2020;20:785-786.
    >> Share


  291. Global outbreak research: harmony not hegemony.
    Lancet Infect Dis. 2020;20:770-772.
    >> Share

    June 2020
  292. DODD RH, Cvejic E, Bonner C, Pickles K, et al
    Willingness to vaccinate against COVID-19 in Australia.
    Lancet Infect Dis. 2020 Jun 30. pii: S1473-3099(20)30559.
    >> Share

  293. ABBAS M, Pittet D
    Surfing the COVID-19 scientific wave.
    Lancet Infect Dis. 2020 Jun 30. pii: S1473-3099(20)30558.
    >> Share

  294. SARDANELLI F, Cozzi A, Monfardini L, Bna C, et al
    Association of mediastinal lymphadenopathy with COVID-19 prognosis.
    Lancet Infect Dis. 2020 Jun 19. pii: S1473-3099(20)30521.
    >> Share

  295. HUBICHE T, Le Duff F, Chiaverini C, Giordanengo V, et al
    Negative SARS-CoV-2 PCR in patients with chilblain-like lesions.
    Lancet Infect Dis. 2020 Jun 18. pii: S1473-3099(20)30518.
    >> Share

  296. PITZER VE, Cohen T
    Household studies provide key insights on the transmission of, and susceptibility to, SARS-CoV-2.
    Lancet Infect Dis. 2020 Jun 17. pii: S1473-3099(20)30514.
    >> Share

  297. JING QL, Liu MJ, Zhang ZB, Fang LQ, et al
    Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
    Lancet Infect Dis. 2020 Jun 17. pii: S1473-3099(20)30471.
    >> Share

  298. AFRA TP, T MR, Bishnoi A, Hafi NB, et al
    Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?
    Lancet Infect Dis. 2020 Jun 16. pii: S1473-3099(20)30472.
    >> Share

  299. MACINTYRE CR
    Case isolation, contact tracing, and physical distancing are pillars of COVID-19 pandemic control, not optional choices.
    Lancet Infect Dis. 2020 Jun 15. pii: S1473-3099(20)30512.
    >> Share

  300. KUCHARSKI AJ, Klepac P, Conlan AJK, Kissler SM, et al
    Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study.
    Lancet Infect Dis. 2020 Jun 15. pii: S1473-3099(20)30457.
    >> Share

  301. TEDDER RS, Semple MG
    Appropriate selection of convalescent plasma donors for COVID-19.
    Lancet Infect Dis. 2020 Jun 15. pii: S1473-3099(20)30470.
    >> Share

  302. NTOUMI F, Velavan TP
    COVID-19 in Africa: between hope and reality.
    Lancet Infect Dis. 2020 Jun 15. pii: S1473-3099(20)30465.
    >> Share

  303. COX RJ, Brokstad KA, Krammer F, Langeland N, et al
    Seroconversion in household members of COVID-19 outpatients.
    Lancet Infect Dis. 2020 Jun 15. pii: S1473-3099(20)30466.
    >> Share


  304. A minimal common outcome measure set for COVID-19 clinical research.
    Lancet Infect Dis. 2020 Jun 12. pii: S1473-3099(20)30483.
    >> Share

  305. OOI EE, Low JG
    Asymptomatic SARS-CoV-2 infection.
    Lancet Infect Dis. 2020 Jun 12. pii: S1473-3099(20)30460.
    >> Share

  306. TABATA S, Imai K, Kawano S, Ikeda M, et al
    Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis.
    Lancet Infect Dis. 2020 Jun 12. pii: S1473-3099(20)30482.
    >> Share

  307. HUNG IF, Cheng VC, Li X, Tam AR, et al
    SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series.
    Lancet Infect Dis. 2020 Jun 12. pii: S1473-3099(20)30364.
    >> Share

  308. THE LANCET INFECTIOUS DISEASES
    Political casualties of the COVID-19 pandemic.
    Lancet Infect Dis. 2020 Jun 11. pii: S1473-3099(20)30496.
    >> Share

  309. CARSANA L, Sonzogni A, Nasr A, Rossi RS, et al
    Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.
    Lancet Infect Dis. 2020 Jun 8. pii: S1473-3099(20)30434.
    >> Share

  310. YI ES, Cecchini MJ, Bois MC
    Pathologists in pursuit of the COVID-19 culprit.
    Lancet Infect Dis. 2020 Jun 8. pii: S1473-3099(20)30449.
    >> Share

  311. MCDONALD ES
    COVID-19 and essential pregnant worker policies.
    Lancet Infect Dis. 2020 Jun 2. pii: S1473-3099(20)30446.
    >> Share

  312. EKTORP E
    Death threats after a trial on chloroquine for COVID-19.
    Lancet Infect Dis. 2020;20:661.
    >> Share

  313. NAKKAZI E
    Obstacles to COVID-19 control in east Africa.
    Lancet Infect Dis. 2020;20:660.
    >> Share

  314. HOLT E
    COVID-19 lockdown of Roma settlements in Slovakia.
    Lancet Infect Dis. 2020;20:659.
    >> Share

  315. KOO JR, Cook AR, Park M, Sun Y, et al
    Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study.
    Lancet Infect Dis. 2020;20:678-688.
    >> Share

  316. MOUSAVI SH, Shah J, Giang HTN, Al-Ahdal TMA, et al
    The first COVID-19 case in Afghanistan acquired from Iran.
    Lancet Infect Dis. 2020;20:657-658.
    >> Share

  317. LEWNARD JA, Lo NC
    Scientific and ethical basis for social-distancing interventions against COVID-19.
    Lancet Infect Dis. 2020;20:631-633.
    >> Share

  318. KELVIN AA, Halperin S
    COVID-19 in children: the link in the transmission chain.
    Lancet Infect Dis. 2020;20:633-634.
    >> Share

  319. RUAN S
    Likelihood of survival of coronavirus disease 2019.
    Lancet Infect Dis. 2020;20:630-631.
    >> Share

  320. THE LANCET INFECTIOUS DISEASES
    Riding the coronacoaster of uncertainty.
    Lancet Infect Dis. 2020;20:629.
    >> Share

  321. HUSSAINI SMQ
    Dearth of infectious diseases physicians as the USA faces a global pandemic.
    Lancet Infect Dis. 2020;20:648-649.
    >> Share

    May 2020
  322. JAMROZIK E, Selgelid MJ
    COVID-19 human challenge studies: ethical issues.
    Lancet Infect Dis. 2020 May 29. pii: S1473-3099(20)30438.
    >> Share

  323. OSORIO NS, Correia-Neves M
    Implication of SARS-CoV-2 evolution in the sensitivity of RT-qPCR diagnostic assays.
    Lancet Infect Dis. 2020 May 28. pii: S1473-3099(20)30435.
    >> Share

  324. WOOD SN, Wit EC, Fasiolo M, Green PJ, et al
    COVID-19 and the difficulty of inferring epidemiological parameters from clinical data.
    Lancet Infect Dis. 2020 May 28. pii: S1473-3099(20)30437.
    >> Share

  325. VERITY R, Okell L, Dorigatti I, Winskill P, et al
    COVID-19 and the difficulty of inferring epidemiological parameters from clinical data - Authors' reply.
    Lancet Infect Dis. 2020 May 28. pii: S1473-3099(20)30443.
    >> Share

  326. TILANGI P, Desai D, Khan A, Soneja M, et al
    Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach.
    Lancet Infect Dis. 2020 May 22. pii: S1473-3099(20)30430.
    >> Share


  327. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation.
    Lancet Infect Dis. 2020 May 20. pii: S1473-3099(20)30426.
    >> Share

  328. BAUCH CT, Anand M
    COVID-19: when should quarantine be enforced?
    Lancet Infect Dis. 2020 May 20. pii: S1473-3099(20)30428.
    >> Share

  329. PEAK CM, Kahn R, Grad YH, Childs LM, et al
    Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study.
    Lancet Infect Dis. 2020 May 20. pii: S1473-3099(20)30361.
    >> Share

  330. HAN MS, Byun JH, Cho Y, Rim JH, et al
    RT-PCR for SARS-CoV-2: quantitative versus qualitative.
    Lancet Infect Dis. 2020 May 20. pii: S1473-3099(20)30424.
    >> Share

  331. MEMISH ZA, Aljerian N, Ebrahim SH
    Tale of three seeding patterns of SARS-CoV-2 in Saudi Arabia.
    Lancet Infect Dis. 2020 May 19. pii: S1473-3099(20)30425.
    >> Share

  332. KHALIL A, Hill R, Ladhani S, Pattisson K, et al
    COVID-19 screening of health-care workers in a London maternity hospital.
    Lancet Infect Dis. 2020 May 18. pii: S1473-3099(20)30403.
    >> Share

  333. GUARNERI C, Rullo EV, Pavone P, Berretta M, et al
    Silent COVID-19: what your skin can reveal.
    Lancet Infect Dis. 2020 May 18. pii: S1473-3099(20)30402.
    >> Share

  334. BUONSENSO D, Parri N, De Rose C, Valentini P, et al
    Toward a clinically based classification of disease severity for paediatric COVID-19.
    Lancet Infect Dis. 2020 May 15. pii: S1473-3099(20)30396.
    >> Share

  335. DE LUSIGNAN S, Dorward J, Correa A, Jones N, et al
    Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.
    Lancet Infect Dis. 2020 May 15. pii: S1473-3099(20)30371.
    >> Share

  336. BOHMER MM, Buchholz U, Corman VM, Hoch M, et al
    Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series.
    Lancet Infect Dis. 2020 May 15. pii: S1473-3099(20)30314.
    >> Share

  337. CHEN D, Tang F, Lu S, Song Q, et al
    Toward a clinically based classification of disease severity for paediatric COVID-19 - Authors' reply.
    Lancet Infect Dis. 2020 May 15. pii: S1473-3099(20)30397.
    >> Share

  338. SIMPSON CR, Thomas BD, Challen K, De Angelis D, et al
    The UK hibernated pandemic influenza research portfolio: triggered for COVID-19.
    Lancet Infect Dis. 2020 May 15. pii: S1473-3099(20)30398.
    >> Share

  339. RYBNIKER J, Fatkenheuer G
    Importance of precise data on SARS-CoV-2 transmission dynamics control.
    Lancet Infect Dis. 2020 May 15. pii: S1473-3099(20)30359.
    >> Share

  340. JORDAN RE, Adab P
    Who is most likely to be infected with SARS-CoV-2?
    Lancet Infect Dis. 2020 May 15. pii: S1473-3099(20)30395.
    >> Share

  341. WRIGHT DJM
    Prevention of the cytokine storm in COVID-19.
    Lancet Infect Dis. 2020 May 7. pii: S1473-3099(20)30376.
    >> Share

  342. LIPSITCH M, Perlman S, Waldor MK
    Testing COVID-19 therapies to prevent progression of mild disease.
    Lancet Infect Dis. 2020 May 6. pii: S1473-3099(20)30372.
    >> Share

  343. WELLS CR, Stearns JK, Lutumba P, Galvani AP, et al
    COVID-19 on the African continent.
    Lancet Infect Dis. 2020 May 6. pii: S1473-3099(20)30374.
    >> Share

  344. MBOPI-KEOU FX, Pondi JE, Sosso MA
    COVID-19 in Cameroon: a crucial equation to resolve.
    Lancet Infect Dis. 2020 May 6. pii: S1473-3099(20)30373.
    >> Share

  345. CHETTERJE P
    Gaps in India's preparedness for COVID-19 control.
    Lancet Infect Dis. 2020;20:544.
    >> Share

  346. RANSCOMBE P
    Rural areas at risk during COVID-19 pandemic.
    Lancet Infect Dis. 2020;20:545.
    >> Share

  347. THE LANCET INFECTIOUS DISEASES
    COVID-19: endgames.
    Lancet Infect Dis. 2020;20:511.
    >> Share

  348. BURKI T
    COVID-19 in Latin America.
    Lancet Infect Dis. 2020;20:547-548.
    >> Share

  349. TO KK, Tsang OT, Leung WS, Tam AR, et al
    Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
    Lancet Infect Dis. 2020;20:565-574.
    >> Share

  350. CHEN Y, Li L
    SARS-CoV-2: virus dynamics and host response.
    Lancet Infect Dis. 2020;20:515-516.
    >> Share

  351. MCBRYDE E
    The value of early transmission dynamic studies in emerging infectious diseases.
    Lancet Infect Dis. 2020;20:512-513.
    >> Share

  352. SIMPSON S, Kaufmann MC, Glozman V, Chakrabarti A, et al
    Disease X: accelerating the development of medical countermeasures for the next pandemic.
    Lancet Infect Dis. 2020;20:e108-e115.
    >> Share

    April 2020
  353. LANG M, Som A, Mendoza DP, Flores EJ, et al
    Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT.
    Lancet Infect Dis. 2020 Apr 30. pii: S1473-3099(20)30367.
    >> Share

  354. ENDEMAN H, van der Zee P, van Genderen ME, van den Akker JPC, et al
    Progressive respiratory failure in COVID-19: a hypothesis.
    Lancet Infect Dis. 2020 Apr 29. pii: S1473-3099(20)30366.
    >> Share

  355. LOHSE S, Pfuhl T, Berko-Gottel B, Rissland J, et al
    Pooling of samples for testing for SARS-CoV-2 in asymptomatic people.
    Lancet Infect Dis. 2020 Apr 28. pii: S1473-3099(20)30362.
    >> Share

  356. SUN K, Viboud C
    Impact of contact tracing on SARS-CoV-2 transmission.
    Lancet Infect Dis. 2020 Apr 27. pii: S1473-3099(20)30357.
    >> Share

  357. NEGIDA A
    Estimation of COVID-19 burden in Egypt.
    Lancet Infect Dis. 2020 Apr 27. pii: S1473-3099(20)30329.
    >> Share

  358. SAHMOUD T
    Estimation of COVID-19 burden in Egypt.
    Lancet Infect Dis. 2020 Apr 27. pii: S1473-3099(20)30318.
    >> Share

  359. BI Q, Wu Y, Mei S, Ye C, et al
    Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study.
    Lancet Infect Dis. 2020 Apr 27. pii: S1473-3099(20)30287.
    >> Share

  360. HASSANY M, Abdel-Razek W, Asem N, AbdAllah M, et al
    Estimation of COVID-19 burden in Egypt.
    Lancet Infect Dis. 2020 Apr 27. pii: S1473-3099(20)30319.
    >> Share

  361. ELMELEEGY K
    Estimation of COVID-19 burden in Egypt.
    Lancet Infect Dis. 2020 Apr 27. pii: S1473-3099(20)30321.
    >> Share

  362. TUITE AR, Ng V, Rees E, Fisman D, et al
    Estimation of COVID-19 burden in Egypt - Authors' reply.
    Lancet Infect Dis. 2020 Apr 27. pii: S1473-3099(20)30326.
    >> Share

  363. YU N, Li W, Kang Q, Zeng W, et al
    No SARS-CoV-2 detected in amniotic fluid in mid-pregnancy.
    Lancet Infect Dis. 2020 Apr 22. pii: S1473-3099(20)30320.
    >> Share

  364. WINTER AK, Hegde ST
    The important role of serology for COVID-19 control.
    Lancet Infect Dis. 2020 Apr 21. pii: S1473-3099(20)30322.
    >> Share

  365. VALETTE X, du Cheyron D, Goursaud S
    Mediastinal lymphadenopathy in patients with severe COVID-19.
    Lancet Infect Dis. 2020 Apr 21. pii: S1473-3099(20)30310.
    >> Share

  366. YONG SEF, Anderson DE, Wei WE, Pang J, et al
    Connecting clusters of COVID-19: an epidemiological and serological investigation.
    Lancet Infect Dis. 2020 Apr 21. pii: S1473-3099(20)30273.
    >> Share

  367. HARGREAVES S, Zenner D, Wickramage K, Deal A, et al
    Targeting COVID-19 interventions towards migrants in humanitarian settings.
    Lancet Infect Dis. 2020 Apr 21. pii: S1473-3099(20)30292.
    >> Share

  368. WELLS CR, Fitzpatrick MC, Sah P, Shoukat A, et al
    Projecting the demand for ventilators at the peak of the COVID-19 outbreak in the USA.
    Lancet Infect Dis. 2020 Apr 20. pii: S1473-3099(20)30315.
    >> Share

  369. GABORIT BJ, Bergmann JF, Mussini C, Arribas JR, et al
    Plea for multitargeted interventions for severe COVID-19.
    Lancet Infect Dis. 2020 Apr 20. pii: S1473-3099(20)30312.
    >> Share

  370. MODJARRAD K, Kim JH
    Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?
    Lancet Infect Dis. 2020 Apr 20. pii: S1473-3099(20)30317.
    >> Share

  371. FOLEGATTI PM, Bittaye M, Flaxman A, Lopez FR, et al
    Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.
    Lancet Infect Dis. 2020 Apr 20. pii: S1473-3099(20)30160.
    >> Share

  372. KOCH T, Dahlke C, Fathi A, Kupke A, et al
    Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial.
    Lancet Infect Dis. 2020 Apr 20. pii: S1473-3099(20)30248.
    >> Share

  373. NELSON R
    COVID-19 disrupts vaccine delivery.
    Lancet Infect Dis. 2020 Apr 17. pii: S1473-3099(20)30304.
    >> Share

  374. GLYNN JR
    Protecting workers aged 60-69 years from COVID-19.
    Lancet Infect Dis. 2020 Apr 16. pii: S1473-3099(20)30311.
    >> Share

  375. BENEZIT F, Le Turnier P, Declerck C, Paille C, et al
    Utility of hyposmia and hypogeusia for the diagnosis of COVID-19.
    Lancet Infect Dis. 2020 Apr 15. pii: S1473-3099(20)30297.
    >> Share

  376. MEYER JP, Franco-Paredes C, Parmar P, Yasin F, et al
    COVID-19 and the coming epidemic in US immigration detention centres.
    Lancet Infect Dis. 2020 Apr 15. pii: S1473-3099(20)30295.
    >> Share

  377. XYDAKIS MS, Dehgani-Mobaraki P, Holbrook EH, Geisthoff UW, et al
    Smell and taste dysfunction in patients with COVID-19.
    Lancet Infect Dis. 2020 Apr 15. pii: S1473-3099(20)30293.
    >> Share

  378. MARTINEZ-PORTILLA RJ, Gonce A, Hawkins-Villarreal A, Figueras F, et al
    A Spanish-translated clinical algorithm for management of suspected SARS-CoV-2 infection in pregnant women.
    Lancet Infect Dis. 2020 Apr 9. pii: S1473-3099(20)30285.
    >> Share

  379. KUCHARSKI AJ, Eggo RM
    Invisible spread of SARS-CoV-2 - Authors' reply.
    Lancet Infect Dis. 2020 Apr 7. pii: S1473-3099(20)30275.
    >> Share

  380. ZHANG W, Qian BY
    Making decisions to mitigate COVID-19 with limited knowledge.
    Lancet Infect Dis. 2020 Apr 7. pii: S1473-3099(20)30280.
    >> Share

  381. XIONG N, Wang T, Lin Z
    Invisible spread of SARS-CoV-2.
    Lancet Infect Dis. 2020 Apr 7. pii: S1473-3099(20)30263.
    >> Share

  382. RICHARDSON PJ, Corbellino M, Stebbing J
    Baricitinib for COVID-19: a suitable treatment? - Authors' reply.
    Lancet Infect Dis. 2020 Apr 3. pii: S1473-3099(20)30270.
    >> Share

  383. FAVALLI EG, Biggioggero M, Maioli G, Caporali R, et al
    Baricitinib for COVID-19: a suitable treatment?
    Lancet Infect Dis. 2020 Apr 3. pii: S1473-3099(20)30262.
    >> Share

  384. DEVI S
    US public health budget cuts in the face of COVID-19.
    Lancet Infect Dis. 2020;20:415.
    >> Share

    March 2020
  385. POLAND GA
    SARS-CoV-2: a time for clear and immediate action.
    Lancet Infect Dis. 2020 Mar 31. pii: S1473-3099(20)30250.
    >> Share

  386. SPYCHALSKI P, Blazynska-Spychalska A, Kobiela J
    Estimating case fatality rates of COVID-19.
    Lancet Infect Dis. 2020 Mar 31. pii: S1473-3099(20)30246.
    >> Share

  387. KIM DD, Goel A
    Estimating case fatality rates of COVID-19.
    Lancet Infect Dis. 2020 Mar 31. pii: S1473-3099(20)30234.
    >> Share

  388. LIPSITCH M
    Estimating case fatality rates of COVID-19.
    Lancet Infect Dis. 2020 Mar 31. pii: S1473-3099(20)30245.
    >> Share

  389. VERITY R, Okell LC, Dorigatti I, Winskill P, et al
    Estimates of the severity of coronavirus disease 2019: a model-based analysis.
    Lancet Infect Dis. 2020 Mar 30. pii: S1473-3099(20)30243.
    >> Share

  390. RAJGOR DD, Lee MH, Archuleta S, Bagdasarian N, et al
    The many estimates of the COVID-19 case fatality rate.
    Lancet Infect Dis. 2020 Mar 27. pii: S1473-3099(20)30244.
    >> Share

  391. LESCURE FX, Bouadma L, Nguyen D, Parisey M, et al
    Clinical and virological data of the first cases of COVID-19 in Europe: a case series.
    Lancet Infect Dis. 2020 Mar 27. pii: S1473-3099(20)30200.
    >> Share

  392. JOYNT GM, Wu WK
    Understanding COVID-19: what does viral RNA load really mean?
    Lancet Infect Dis. 2020 Mar 27. pii: S1473-3099(20)30237.
    >> Share

  393. HUANG Y, Cheng W, Zhao N, Qu H, et al
    CT screening for early diagnosis of SARS-CoV-2 infection.
    Lancet Infect Dis. 2020 Mar 26. pii: S1473-3099(20)30241.
    >> Share

  394. SHI H, Han X, Cao Y, Alwalid O, et al
    CT screening for early diagnosis of SARS-CoV-2 infection - Authors' reply.
    Lancet Infect Dis. 2020 Mar 26. pii: S1473-3099(20)30247.
    >> Share

  395. TUITE AR, Ng V, Rees E, Fisman D, et al
    Estimation of the COVID-19 burden in Egypt through exported case detection.
    Lancet Infect Dis. 2020 Mar 26. pii: S1473-3099(20)30233.
    >> Share

  396. QIU H, Wu J, Hong L, Luo Y, et al
    Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study.
    Lancet Infect Dis. 2020 Mar 25. pii: S1473-3099(20)30198.
    >> Share

  397. LUO Y, Yin K
    Management of pregnant women infected with COVID-19.
    Lancet Infect Dis. 2020 Mar 24. pii: S1473-3099(20)30191.
    >> Share

  398. YU N, Li W, Kang Q, Xiong Z, et al
    Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study.
    Lancet Infect Dis. 2020 Mar 24. pii: S1473-3099(20)30176.
    >> Share

  399. TUITE AR, Ng V, Rees E, Fisman D, et al
    Estimation of COVID-19 outbreak size in Italy.
    Lancet Infect Dis. 2020 Mar 19. pii: S1473-3099(20)30227.
    >> Share

  400. LIU Y, Yan LM, Wan L, Xiang TX, et al
    Viral dynamics in mild and severe cases of COVID-19.
    Lancet Infect Dis. 2020 Mar 19. pii: S1473-3099(20)30232.
    >> Share

  401. SCHMID MB, Fontijn J, Ochsenbein-Kolble N, Berger C, et al
    COVID-19 in pregnant women.
    Lancet Infect Dis. 2020 Mar 17. pii: S1473-3099(20)30175.
    >> Share

  402. BAUD D, Giannoni E, Pomar L, Qi X, et al
    COVID-19 in pregnant women - Authors' reply.
    Lancet Infect Dis. 2020 Mar 17. pii: S1473-3099(20)30192.
    >> Share

  403. THE LANCET INFECTIOUS DISEASES
    COVID-19, a pandemic or not?
    Lancet Infect Dis. 2020 Mar 13. pii: S1473-3099(20)30180.
    >> Share

  404. BAUD D, Qi X, Nielsen-Saines K, Musso D, et al
    Real estimates of mortality following COVID-19 infection.
    Lancet Infect Dis. 2020 Mar 12. pii: S1473-3099(20)30195.
    >> Share

  405. HAN H, Luo Q, Mo F, Long L, et al
    SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients.
    Lancet Infect Dis. 2020 Mar 12. pii: S1473-3099(20)30174.
    >> Share

  406. KUCHARSKI AJ, Russell TW, Diamond C, Liu Y, et al
    Early dynamics of transmission and control of COVID-19: a mathematical modelling study.
    Lancet Infect Dis. 2020 Mar 11. pii: S1473-3099(20)30144.
    >> Share

  407. ZHOU C, Gao C, Xie Y, Xu M, et al
    COVID-19 with spontaneous pneumomediastinum.
    Lancet Infect Dis. 2020 Mar 9. pii: S1473-3099(20)30156.
    >> Share

  408. WILDER-SMITH A, Chiew CJ, Lee VJ
    Can we contain the COVID-19 outbreak with the same measures as for SARS?
    Lancet Infect Dis. 2020 Mar 5. pii: S1473-3099(20)30129.
    >> Share

  409. XIAO Y, Torok ME
    Taking the right measures to control COVID-19.
    Lancet Infect Dis. 2020 Mar 5. pii: S1473-3099(20)30152.
    >> Share

  410. YAN G, Lee CK, Lam LTM, Yan B, et al
    Covert COVID-19 and false-positive dengue serology in Singapore.
    Lancet Infect Dis. 2020 Mar 4. pii: S1473-3099(20)30158.
    >> Share

  411. THANH HN, Van TN, Thu HNT, Van BN, et al
    Outbreak investigation for COVID-19 in northern Vietnam.
    Lancet Infect Dis. 2020 Mar 4. pii: S1473-3099(20)30159.
    >> Share

  412. FAVRE G, Pomar L, Qi X, Nielsen-Saines K, et al
    Guidelines for pregnant women with suspected SARS-CoV-2 infection.
    Lancet Infect Dis. 2020 Mar 3. pii: S1473-3099(20)30157.
    >> Share

  413. THE LANCET INFECTIOUS DISEASES
    Challenges of coronavirus disease 2019.
    Lancet Infect Dis. 2020;20:261.
    >> Share

  414. BURKI T
    Outbreak of coronavirus disease 2019.
    Lancet Infect Dis. 2020;20:292-293.
    >> Share

  415. BASTOLA A, Sah R, Rodriguez-Morales AJ, Lal BK, et al
    The first 2019 novel coronavirus case in Nepal.
    Lancet Infect Dis. 2020;20:279-280.
    >> Share

  416. LI J, Li JJ, Xie X, Cai X, et al
    Game consumption and the 2019 novel coronavirus.
    Lancet Infect Dis. 2020;20:275-276.
    >> Share

    February 2020
  417. HUANG R, Xia J, Chen Y, Shan C, et al
    A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China.
    Lancet Infect Dis. 2020 Feb 28. pii: S1473-3099(20)30147.
    >> Share

  418. CHEN L, Xiong J, Bao L, Shi Y, et al
    Convalescent plasma as a potential therapy for COVID-19.
    Lancet Infect Dis. 2020 Feb 27. pii: S1473-3099(20)30141.
    >> Share

  419. STEBBING J, Phelan A, Griffin I, Tucker C, et al
    COVID-19: combining antiviral and anti-inflammatory treatments.
    Lancet Infect Dis. 2020 Feb 27. pii: S1473-3099(20)30132.
    >> Share

  420. LEE EYP, Ng MY, Khong PL
    COVID-19 pneumonia: what has CT taught us?
    Lancet Infect Dis. 2020 Feb 24. pii: S1473-3099(20)30134.
    >> Share

  421. PAN Y, Zhang D, Yang P, Poon LLM, et al
    Viral load of SARS-CoV-2 in clinical samples.
    Lancet Infect Dis. 2020 Feb 24. pii: S1473-3099(20)30113.
    >> Share

  422. SHI H, Han X, Jiang N, Cao Y, et al
    Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.
    Lancet Infect Dis. 2020 Feb 24. pii: S1473-3099(20)30086.
    >> Share

  423. PAN X, Chen D, Xia Y, Wu X, et al
    Asymptomatic cases in a family cluster with SARS-CoV-2 infection.
    Lancet Infect Dis. 2020 Feb 19. pii: S1473-3099(20)30114.
    >> Share

  424. XU B, Kraemer MUG
    Open access epidemiological data from the COVID-19 outbreak.
    Lancet Infect Dis. 2020 Feb 19. pii: S1473-3099(20)30119.
    >> Share

  425. DONG E, Du H, Gardner L
    An interactive web-based dashboard to track COVID-19 in real time.
    Lancet Infect Dis. 2020 Feb 19. pii: S1473-3099(20)30120.
    >> Share

  426. CHEN X, Tian J, Li G, Li G, et al
    Initiation of a new infection control system for the COVID-19 outbreak.
    Lancet Infect Dis. 2020 Feb 18. pii: S1473-3099(20)30110.
    >> Share

  427. VAN CUONG L, Giang HTN, Linh LK, Shah J, et al
    The first Vietnamese case of COVID-19 acquired from China.
    Lancet Infect Dis. 2020 Feb 18. pii: S1473-3099(20)30111.
    >> Share

  428. THOMPSON R
    Pandemic potential of 2019-nCoV.
    Lancet Infect Dis. 2020 Feb 7. pii: S1473-3099(20)30068.
    >> Share

  429. BAGCCHI S
    Mysterious pneumonia in China.
    Lancet Infect Dis. 2020;20:173.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016